Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

Abstract

High BMI is a prognostic factor for improved survival and progression-free survival in patients with metastatic RCC treated with targeted therapy. Underlying biology suggests a role for the FASN pathway.